Exciting News! Lotus Clinical Research is now powered by ETQ Reliance Quality Management System! We are thrilled to announce that Lotus Clinical Research has joined ETQ’s Reliance QMS. With ETQ Reliance, Lotus has digitized manual processes, centralized quality data, and automated core functions like document control and CAPA Plans. This partnership has greatly enhanced our … Read more
South Rampart Pharma Announces First Patient Enrolled in Multiple Ascending Dose Portion of Ongoing Phase 1 Clinical Trial – SRP-001, a novel, non-opioid investigational drug that avoids the liver toxicity associated with acetaminophen, positioned to address the unmet medical need for non-toxic and non-addictive acute and chronic pain therapeutics – – Data expected in 3Q 2023 – NEW … Read more
We are very excited to introduce Erin Berg as our Director of Project Management at Lotus Clinical Research. In her role, Erin will be leveraging her extensive experience to oversee and deliver Early Development Service (EDS) trials. With a wealth of experience and a proven track record of success in global project management and clinical study … Read more
Lotus and ERG effectively kick off their inaugural internal CRA Academy! Cassie Witte asks the creator and facilitator of the CRA Academy, Marilyn Greenwalt, and two of the Academy’s graduates Cooper Nelson and Nicole Johnson, some questions about this initiative. Interested in learning more about our CRA Academy? Check out the video below!
We are thrilled to introduce Sandra Winsett as the Director of Clinical Systems at Lotus Clinical Research! Sandra brings over 15 years of experience in the field of clinical systems as well as a deep understanding of the intersection between technology and healthcare. With a degree in Health Informatics and a proven track record of … Read more
We are delighted to announce that our Vice President of Clinical Development, Erin Tireman, Psy.D, will now be overseeing medical writing services as an expansion of her current leadership role within Lotus’ Scientific Services division.
Fast-growing CRO utilizes Veeva Vault Clinical Suite to substantially decrease startup time — Veeva Systems (NYSE: VEEV) today announced that Lotus Clinical Research expanded its partnership with Veeva..
At Lotus Clinical Research, the safety of our patients, employees and customers remains our highest priority.
In the coming weeks and months, in accordance with public health department…
September is Pain Awareness Month! Lotus Clinical Research’s mission is to reduce prescription drug misuse and abuse by inventing and validating scientific technologies that improve analgesic study design and conduct.
When it comes to subject dropouts, an ounce of prevention is worth a pound of cure. Lotus Clinical Research has created a subject and investigator education series that can reduce subject dropout rates.
© 2023 Lotus Clinical Research, LLC. All Rights Reserved
